Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-13

Clinical Trial Update: Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux

View source ↗

Summary

The study evaluated whether oropharyngeal pepsin levels correlate with gastroesophageal reflux in patients with GERD. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Gastroesophageal Reflux Disease (GERD) | Status: COMPLETED